ARCHIVES

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Still Lingering, Bills ‘Tie Hands’ Of NCI Director

October 18, 1991

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

RFA/PA/Drug Group Announcement Limited

May 6, 1988

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013